MB2PROF
Marqueurs Biologiques Des Bronchopneumopathies Chroniques Obstructives Professionnelles
Sponsor study identifier
observational
400
1 country
1
Study Start
January 2010
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2016
Actual (reported)Study Completion
January 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Chronic obstructive pulmonary disease (COPD) is a frequent disease, mainly linked to tobacco smoking leading to chronic respiratory failure. It is characterized by an inflammatory spate with modification of protease-antiprotease and oxidant-antioxydant balances. Local modifications are associated with systemic changes. Many occupational factors have been associated with an excess of COPD in epidemiological studies, however without identification of any specific clinical or biological phenotype. Pathophysiological pathways involved in COPD might be different according to etiologic agents. Therefore, it is important to focus research on blood biomarkers associated with some well-characterized occupational COPD. The objectives of MB2PROF project are:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 2010
Date type not reportedThis date has not been verified as actual or estimated.
January 2016
Actual (reported)September 23, 2016
Actual (reported)August 7, 2017
Actual (reported)January 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
C Protein Reactive
at year 1
blood inflammatory markers
at year 1
C Protein Reactive
every year during 5 years
blood inflammatory markers
every year during 5 years
COPD and healthy subjects exposed to tobacco smoking and/or to occupational dust
CHI Créteil
Créteil, 94000, France
Blood samples
First Submitted
September 23, 2016
First Posted
August 7, 2017
Study Start
January 2010
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2016
Contact the study team to confirm eligibility.
Study Completion
January 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
August 30, 2017
Record last verified: 2017-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: